SCHEMBL17097883

SCHEMBL17097883

O=C(CN(Cc1cncnc1)C(=O)c1cnn(C2CCC(C(=O)O)CC2)c1C(F)(F)F)c1c(Cl)cccc1Cl

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 9/20 0.33
ITGB1 P05556 1/20 0.31
ITGA4 P13612 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HSD11B1 P28845 1/20 0.31
MEN1 O00255 2/20 0.30
KMT2A Q03164 2/20 0.30
NPSR1 Q6W5P4 2/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
MAPT P10636 1/20 0.30
CCR5 P51681 1/20 0.30
DDR1 Q08345 1/20 0.30
MAPK11 Q15759 1/20 0.30
MAPK14 Q16539 1/20 0.30
DDR2 Q16832 1/20 0.30
TMEM97 Q5BJF2 1/20 0.30
MAP3K20 Q9NYL2 1/20 0.30
MAP3K2 Q9Y2U5 1/20 0.30
NR3C1 P04150 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17097881 1.00 RORC (0.33) RORCITGB1ITGA4KDM4EALDH1A1
SCHEMBL17110623 0.90 TAS2R14 (0.35) RORCKDM4EALDH1A1MAPTNR3C1
SCHEMBL17098718 0.90 NR3C1 (0.36) RORCMAPTCCR5DDR1MAPK11
SCHEMBL17098716 0.90 NR3C1 (0.36) RORCMAPTCCR5DDR1MAPK11
SCHEMBL17098772 0.90 RORC (0.34) RORCMEN1KMT2ANPSR1SMN1; SMN2
SCHEMBL17098774 0.90 RORC (0.34) RORCMEN1KMT2ANPSR1SMN1; SMN2
SCHEMBL17098615 0.89 CCR5 (0.38) KDM4EALDH1A1MEN1KMT2ANPSR1
SCHEMBL17098618 0.89 CCR5 (0.38) KDM4EALDH1A1MEN1KMT2ANPSR1
SCHEMBL17098001 0.89 RORC (0.32) RORC
SCHEMBL17097998 0.89 RORC (0.32) RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9365522-B2 Pyrazole amide derivative AMGEN INC. (US) 2016-06-14 US claimed
US-20150266824-A1 Pyrazole Amide Derivative TEIJIN LIMITED (JP) 2015-09-24 US claimed
EP-3110810-B1 PYRAZOLE AMIDE DERIVATIVE TEIJIN PHARMA LTD (JP) 2018-05-02 EP disclosed
US-9365522-B2 Pyrazole amide derivative AMGEN INC. (US) 2016-06-14 US disclosed
US-20150266824-A1 Pyrazole Amide Derivative TEIJIN LIMITED (JP) 2015-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150266824-A1 Pyrazole Amide Derivative RORC, RORB, RORA RORC 1/4885ITGB1 4448/4885ITGA4 4390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.